Scangos grabs the spotlight amid Biogen Idec's surge; Sanofi exec talks up data transparency;

 @FierceBiotech: In Alzheimer's mystery, key biomarker will determine success of pivotal studies. Story | Follow @FierceBiotech

@JohnCFierce: At the very least, Merck should redesign the patient selection process on MK-8931 and concentrate on mild/prodromal Alzheimer's cases only. | Follow @JohnCFierce

 @RyanMFierce: AstraZeneca has answered German price cuts to drugs with $AZN workforce cuts of 400-650 workers in the country. Release | Follow @RyanMFierce

> Lundbeck CEO Ulf Wiinberg predicts 2013 to bring a "feast" of potential regulatory wins after battling generics competition. Article

> Biogen Idec ($BIIB) CEO George Scangos is featured in a Forbes article on the big biotech's comeback. Item

> FDA staff out the potential for abuse of Zogenix's pain drug. Item

> Peregrine ($PPHM) says (again) that the FDA has cleared the company's plans for late-stage development of Cotara for treating brain tumors. Report

> GlaxoSmithKline ($GSK) has raised doubts about diabetes drugs in the GLP-1 class serving as obesity treatments. Article

Pharma News

@FiercePharma: Eli Lilly taps India's Strides Arcolab to make/distribute generic cancer drugs in emerging markets. More | Follow @FiercePharma

> Indian bureaucrats decide to review all foreign pharma investments. More

> Closely watched Novartis patent case wraps in India. Story

> AZ blames German pricing for 400 job cuts. Article

Medical Device News

 @FierceMedDev: SurgiQuest pulled in $18.5M in new funding for an abdominal cavity surgical tool. Release | Follow @FierceMedDev

@MarkHFierce: Another day, another lawsuit against a faulty metal hip replacement--this time against Biomet. Story | Follow @MarkHFierce

 @DamianFierce: The Israeli medical device industry is on the up-and-up, and Medtronic is paying attention, an exec says. News | Follow @DamianFierce

> Device startup nails $3.64M Series A for hemorrhage-control device. Item

> Kona Medical closes $40M round for renal denervation device. News

Drug Delivery News

> Leukemia nanoparticles get drugs to the right spot. News

> Team shoos away superbugs with puffs of powder. Report

> Iluvien stumbles on rocky road to market in U.K. Article

> Dissolving fabric could stop pregnancy, HIV. Story

Biomarkers News

> Experts: Britain's NHS must build genetic testing infrastructure. News

> In Alzheimer's mystery, key biomarker will determine success of pivotal studies. Article

> Supreme Court to tackle gene patent case. Item

> Gene analysis marks new targets against childhood cancer. Report

> Biotech grabs $2M to discover biomarkers for personalized autism treatment. News

> Biomarker spotted for colon cancer stem cells. Story

And Finally… Sanofi ($SNY) strategy chief David-Alexandre Gros has joined the small but growing number of pharma execs talking up transparency of raw data from clinical trials. Report

Suggested Articles

A TGen-led research team found that increased activity of the gene AEBP1 drives severe liver fibrosis in nonalcoholic steatohepatitis.

Days after announcing its R&D chief was stepping down, Gilead announced it will be buying a few of Novartis’ unwanted early-stage infection assets.

Mallinckrodt is teaming up with Silence Therapeutics to develop an RNAi program aimed at a group of proteins that play a part in promoting inflammation.